Expression and significance of serum high mobility group protein A1 in patients with metabolic associated fatty liver disease

CHENG Yinfei; HUANG Wei; LU Cuihua

doi:10.7619/jcmp.20212993

Journal of Clinical Medicine in Practice > 2022 > 26(1): 76-79. > DOI: 10.7619/jcmp.20212993

CHENG Yinfei, HUANG Wei, LU Cuihua. Expression and significance of serum high mobility group protein A1 in patients with metabolic associated fatty liver disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 76-79. DOI: 10.7619/jcmp.20212993

Citation:

PDF (1910 KB)

Expression and significance of serum high mobility group protein A1 in patients with metabolic associated fatty liver disease

1.
Department of Gastroenterology, Rudong County People′s Hospital in Jiangsu Province, Nantong, Jiangsu, 226000
2.
Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226000

More Information

Received Date: July 25, 2021
Available Online: January 19, 2022
Published Date: January 14, 2022

Graphical Abstract

Abstract

Abstract

Objective To analyze the expression and significance of serum high mobility group protein A1 (HMGA1) in patients with metabolic associated fatty liver disease (MAFLD).
Methods A total of 34 patients diagnosed as MAFLD in Rudong County People′s Hospital in Jiangsu Province from May 2020 to January 2021 were selected as MAFLD group, and 36 healthy people with physical examinations were selected as control group. Indexes such as height, weight, body mass index (BMI), serum interleukin-6 (IL-6), glucose (GLU), glycated hemoglobin (GHb), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyl transpeptidase (GGT) and HMGA1 were compared between two groups.
Results The content of HMGA1 in the MAFLD group was (11.97±0.45) ng/mL, which was significantly higher than (8.34±0.40) ng/mL in the control group (P < 0.01). HMGA1 was positively correlated with BMI, IL-6, GLU, GHb, TG and ALT (P < 0.05 or P < 0.01). Multiple linear regression analysis showed that HMGA1 was significantly correlated with IL-6 (P < 0.05).
Conclusion Serum HMGA1 in patients with MAFLD increases significantly and is positively correlated with IL-6, which indicate that HMGA1 plays an important role in the pathogenesis of MAFLD, and it may reflect the severity of the disease.
- metabolic associated fatty liver disease,
- high mobility group protein A1,
- interleukin-6,
- pathogenesis,
- correlation

FullText(HTML)

References (20)

References

[1]	ESLAM M, NEWSOME P N, SARIN S K, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement[J]. J Hepatol, 2020, 73(1): 202-209. doi: 10.1016/j.jhep.2020.03.039
[2]	ENOOKU K, NAKAGAWA H, FUJIWARA N, et al. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma[J]. Sci Rep, 2019, 9(1): 10663. doi: 10.1038/s41598-019-47216-2
[3]	夏明锋, 卞华, 高鑫. 从非酒精性脂肪肝到代谢相关性脂肪肝命名变化的思考[J]. 中华糖尿病杂志, 2020, 12(7): 445-450. doi: 10.3760/cma.j.cn115791-20200324-00175
[4]	ZHANG Q H, CHEN L, ZHAO Z B, et al. HMGA1 mediated high-glucose-induced vascular smooth muscle cell proliferation in diabetes mellitus: association between PI3K/Akt signaling and HMGA1 expression[J]. DNA Cell Biol, 2018, 37(4): 389-397. doi: 10.1089/dna.2017.3957
[5]	PERLAZA R N A. Facial soft tissue thickness of Colombian adults[J]. Forensic Sci Int, 2013, 229(1/2/3): 160. e1-160. e9.
[6]	CHEN W, WANG Y, WU J, et al. Incomplete capsulotomy and lens fragmentation during femtosecond laser-assisted cataract surgery associated with emulsified anterior chamber silicone oil: a case report[J]. Int J Ophthalmol, 2019, 12(6): 1047-1049.
[7]	RAVE-FRÄNK M, MALIK I A, CHRISTIANSEN H, et al. Rat model of fractionated (2 Gy/day) 60 Gy irradiation of the liver: long-term effects[J]. Radiat Environ Biophys, 2013, 52(3): 321-338. doi: 10.1007/s00411-013-0468-7
[8]	ESLAM M, SANYAL A J, GEORGE J, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease[J]. Gastroenterology, 2020, 158(7): 1999-2014, e1. doi: 10.1053/j.gastro.2019.11.312
[9]	WU D D, LIU J, CHEN J L, et al. miR-449a suppresses tumor growth, migration, and invasion in non-small cell lung cancer by targeting a HMGB1-mediated NF-κB signaling pathway[J]. Oncol Res, 2019, 27(2): 227-235. doi: 10.3727/096504018X15213089759999
[10]	WEI F, ZHANG T, DENG S C, et al. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways[J]. Cancer Lett, 2019, 450: 1-13. doi: 10.1016/j.canlet.2019.02.022
[11]	EBISAWA K, MASAMOTO Y, KUROKAWA M. HMGA1 is upregulated in myelodysplastic syndromes with mutation in pre-mRNA splicing genes and inhibits leukemia cell differentiation[J]. Blood, 2020, 136: 32.
[12]	ZHANG C, CHEN F, FENG L, et al. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease[J]. Mol Med, 2019, 25(1): 29. doi: 10.1186/s10020-019-0099-9
[13]	王珊, 张健, 张杰, 等. 体质量指数轨迹与新发非酒精性脂肪性肝病相关性的队列研究[J]. 中华肝脏病杂志, 2020, 28(7): 597-602. doi: 10.3760/cma.j.cn501113-20190629-00230
[14]	MANSOUR-GHANAEI R, MANSOUR-GHANAEI F, NAGHIPOUR M, et al. The role of anthropometric indices in the prediction of non-alcoholic fatty liver disease in the PERSIAN Guilan Cohort study (PGCS)[J]. J Med Life, 2018, 11(3): 194-202. doi: 10.25122/jml-2018-0031
[15]	SCHMIDT-ARRAS D, ROSE-JOHN S. IL-6 pathway in the liver: from physiopathology to therapy[J]. J Hepatol, 2016, 64(6): 1403-1415. doi: 10.1016/j.jhep.2016.02.004
[16]	SIEWKO K, MACIULEWSKI R, ZIELINSKA-MACIULEWSKA A, et al. Interleukin-6 and interleukin-15 as possible biomarkers of the risk of autoimmune diabetes development[J]. Biomed Res Int, 2019, 2019: 4734063.
[17]	TAN S Y, LEI X, LITTLE H C, et al. CTRP12 ablation differentially affects energy expenditure, body weight, and insulin sensitivity in male and female mice[J]. Am J Physiol Endocrinol Metab, 2020, 319(1): E146-E162. doi: 10.1152/ajpendo.00533.2019
[18]	WANG X L, HUANG T, XIE H. CTRP12 alleviates isoproterenol induced cardiac fibrosis via inhibiting the activation of P38 pathway[J]. Chem Pharm Bull (Tokyo), 2021, 69(2): 178-184. doi: 10.1248/cpb.c19-01109
[19]	叶晓贤, 杨丽, 雷丽. 血清糖化血红蛋白和IL-6对非酒精性脂肪性肝病发病风险的预测价值探讨[J]. 实用肝脏病杂志, 2020, 23(2): 199-202. doi: 10.3969/j.issn.1672-5069.2020.02.013
[20]	DAMAVANDI N, ZEINALI S. Association of xenobiotic-metabolizing enzymes (GSTM1 and GSTT 1), and pro-inflammatory cytokines (TNF-α and IL-6) genetic polymorphisms with non-alcoholic fatty liver disease[J]. Mol Biol Rep, 2021, 48(2): 1225-1231. doi: 10.1007/s11033-021-06142-1

[1]	WANG Yu, YANG Jixue, GUO Dianqu, LIU Wenbin. Relationships of expression of high mobility group box 1 protein and toll-like receptor 4 in patients with clinical characteristics of refractory epilepsy and their predictive value[J]. Journal of Clinical Medicine in Practice, 2024, 28(19): 68-72, 83. DOI: 10.7619/jcmp.20241965
[2]	ZHENG Junqi, LIU Xiangyan. Distribution of pulmonary infection pathogens after lung cancer chemotherapy and diagnostic values of serum cytokeratin 19 fragment antigen, high mobility group box 1 protein and soluble hemoglobin scavenger receptor[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 7-11. DOI: 10.7619/jcmp.20241847
[3]	ZHAO Congcong, QI Wenmei. Mechanism of Xueshuantong injection combined with intravenous thrombolysis with alteplase in treatment of patients with acute cerebral infarction based on high mobility group protein B1/Toll-like receptor 4 signaling pathway[J]. Journal of Clinical Medicine in Practice, 2024, 28(13): 41-46. DOI: 10.7619/jcmp.20234027
[4]	YU Xinran, FENG Bing. Prognostic value of ratio of monocyte to high-density lipoprotein combined with high mobility group protein B1 in patients with septic myocardial injury[J]. Journal of Clinical Medicine in Practice, 2023, 27(23): 86-90, 94. DOI: 10.7619/jcmp.20232314
[5]	GAO Jianying, CAO Wenjuan, GAO Yuan. Values of D-dimer, prealbumin and soluble triggering receptor expressed on myeloid cells-1 in diagnosing severe pneumonia in children[J]. Journal of Clinical Medicine in Practice, 2023, 27(7): 108-112. DOI: 10.7619/jcmp.20223481
[6]	CHEN Yanrong, LIU Yan, WANG Shan, ZHANG Jing. Expression characteristics and detection value of histamine, soluble myeloid cell trigger receptor-1, microribonuclease-145 and high-sensitivity C-reactive protein in patients with chronic obstructive pulmonary disease and coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2023, 27(3): 1-5. DOI: 10.7619/jcmp.20223161
[7]	MENG Chao, FAN Zhiqiang, TONG Qing, ZHU Guijun, ZHU Hui. Value of prognostic assessment of soluble triggering receptor expressed on myeloid cell-1, high-sensitivity C-reactive protein combined with the Acute Physiology and Chronic Health Evaluation Ⅱ score in patients with pneumonia complicated with respiratory failure[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 88-92, 101. DOI: 10.7619/jcmp.20211056
[8]	CAI Shaoying, YE Liling, ZHANG Pingheng, MAO Haifei, LIN Guoxiong. Effects of different anesthesia methods on postoperative cognitive function and high mobility group protein B1 for patients undergoing gastrointestinal surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(4): 41-44. DOI: 10.7619/jcmp.20201189
[9]	ZHANG Ye, ZHUANG Xueming, YU Dawei, XU Dongsheng, ZHANG Li, WANG Zhongxiang, WANG Shibo. Value of serum high mobility group box 1 combined with modified Edinburgh-Scandinavian Stroke Scale score in evaluating prognosis of acute ischemic stroke patients with intravenous thrombolysis[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 23-27. DOI: 10.7619/jcmp.20201140
[10]	LIU Ping, MEI Hong. Effect of low-dose hormone on serum soluble triggering receptor expressed on myeloid cells-1, procalcitonin and CD64 in children with sepsis[J]. Journal of Clinical Medicine in Practice, 2017, (15): 41-44,48. DOI: 10.7619/jcmp.201715011

Cited By

Cited by

Periodical cited type(13)

1.	鲍颍松，盛强，王珊，贾健安，童清平. 血清sTLT-1、ESM-1对ICU患者发生输血相关急性肺损伤的诊断价值. 检验医学与临床. 2025(01): 91-95 .
2.	张建新，马尚超，宋浩，殷飞，崔俊伟. 脓毒症患者血清HMGB1、sTLT-1、NLR变化及其对并发急性肺损伤的预测价值. 海南医学. 2024(12): 1736-1739 .
3.	李志丹，杨璐瑜，曹松，陆辉志. 血清HMGB1、TIMP-2水平与脓毒症急性肾损伤预后的相关性研究. 中国急救复苏与灾害医学杂志. 2024(07): 892-895 .
4.	曾玉龙，陈玲玲，陈相. 急性大出血患者血清CCL25和sTLT-1水平表达与输血相关性急性肺损伤发生的相关性研究. 现代检验医学杂志. 2024(04): 126-130 .
5.	沃琦，汪秀英，杜腾飞，冯棋佳，戴志春，朱静文. 急性感染性腹膜炎并发急性肺损伤外周血CXCR4和sTLT-1水平. 中华医院感染学杂志. 2024(22): 3408-3411 .
6.	王晓林，李静，范志强，佟庆，黄艳丽. 血清sTLT-1、SP-D、NF-κB水平在脓毒症急性肺损伤预后评估中的价值. 西部医学. 2024(12): 1781-1785 .
7.	李丹丹，张由建，靳津鸽. 血清相关细胞因子水平变化与急性心肌梗死患者 MACE风险的相关性研究. 医学理论与实践. 2023(10): 1726-1728 .
8.	焦相赟，吴金海，李翠英，李想. 脓毒血症合并急性肾损伤患者经CRRT联合血液灌注疗法治疗的疗效评价. 中国疗养医学. 2023(07): 759-762 .
9.	杜叶子，杨皓莹，段璠. 血清HMGB1、IL-33与再生障碍性贫血患儿病情严重程度及免疫状态的相关性分析. 国际检验医学杂志. 2023(16): 1949-1952+1957 .
10.	左扬松，周素芹，王丽莉，张玉凤，季擎天，王喆，李亚伟. 脓毒症相关急性肺损伤患者趋化因子受体4、可溶性髓样细胞触发受体样转录因子-1检测价值探讨. 实用医院临床杂志. 2023(06): 84-86 .
11.	刘瑞瑞，张树柳，王军芳，田昭涛，崔云亮. 乌司他丁对脓毒症大鼠肺损伤的保护作用及机制研究. 联勤军事医学. 2023(10): 827-830 .
12.	瞿红娟，万鲁云，桂春喜，王璐. 血清CXCR4和HMGB1水平在预测急性大出血患者输血相关性急性肺损伤预后中的价值研究. 临床和实验医学杂志. 2022(13): 1390-1393 .
13.	王慧，龚园其，周仪华，蓝海兵，张啸. 青藤碱调控Nrf2/Keap1信号通路对脓毒症急性肺损伤的改善作用. 实用医学杂志. 2022(15): 1896-1900 .

Other cited types(1)

Get Citation

PDF

XML

Article views (274) PDF downloads (8) Cited by(14)

Turn off MathJax

Article Contents

Abstract

References

Expression and significance of serum high mobility group protein A1 in patients with metabolic associated fatty liver disease